13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q3 2023 · Filed July 19, 2023 · Accession 0000950123-23-006158
Total Value
$356.9M
Positions
6
Other Managers
1
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $123.6M | 34.62% |
| 2 | VAXCYTE INC | PCVX | 1,315,435 | $65.7M | 18.41% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 3,760,869 | $53.9M | 15.09% |
| 4 | MERUS N V | N5749R100 | 1,600,000 | $42.1M | 11.80% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $37.5M | 10.52% |
| 6 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $34.1M | 9.56% |